Literature DB >> 11821072

Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome.

John E Nestler1, Dale Stovall, Nausheen Akhter, Maria J Iuorno, Daniela J Jakubowicz.   

Abstract

OBJECTIVE: Insulin resistance and its compensatory hyperinsulinemia play a key pathogenic role in the infertility of the polycystic ovary syndrome. Numerous studies indicate that insulin-sensitizing drugs can be used to enhance spontaneous ovulation and the induction of ovulation in the syndrome. The aim of this review is to summarize the studies in which insulin-sensitizing drugs were used to increase ovulation rate or improve fertility in women with the PCOS and to translate the information into practical guidelines for the use of these drugs by reproductive endocrinologists.
DESIGN: Review and critique of studies in which an insulin-sensitizing drug was used to increase ovulation rate or improve infertility in women with the polycystic ovary syndrome. MAIN OUTCOME MEASURE(S): Ovulation rate and pregnancy rate. RESULT(S): Studies have demonstrated that insulin-sensitizing drugs can increase spontaneous ovulation, enhance the induction of ovulation with clomiphene citrate, and increase clinical pregnancy rates. CONCLUSION(S): An algorithmic approach is provided for the use of insulin-sensitizing drugs to treat the anovulation and infertility of women with the polycystic ovary syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821072     DOI: 10.1016/s0015-0282(01)02963-6

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  28 in total

1.  Effects of low-dose metformin in Japanese women with clomiphene-resistant polycystic ovary syndrome.

Authors:  Takumi Kurabayashi; Mina Suzuki; Katsunori Kashima; Junichi Banzai; Kyoko Terabayashi; Kazuyuki Fujita; Kenichi Tanaka
Journal:  Reprod Med Biol       Date:  2004-03-30

2.  Waist circumference in relation to outcomes of infertility treatment with assisted reproductive technologies.

Authors:  Ming-Chieh Li; Lidia Mínguez-Alarcón; Mariel Arvizu; Yu-Han Chiu; Jennifer B Ford; Paige L Williams; Jill Attaman; Russ Hauser; Jorge E Chavarro
Journal:  Am J Obstet Gynecol       Date:  2019-02-11       Impact factor: 8.661

Review 3.  The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer.

Authors:  Vladimir N Anisimov; Andrzej Bartke
Journal:  Crit Rev Oncol Hematol       Date:  2013-02-21       Impact factor: 6.312

4.  The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study.

Authors:  Sedigheh Ghandi; Abbas Aflatoonian; Nasim Tabibnejad; Mohammad Hossein Sojoodi Moghaddam
Journal:  J Assist Reprod Genet       Date:  2011-04-12       Impact factor: 3.412

5.  Commonly used fertility drugs, a diet supplement, and stress force AMPK-dependent block of stemness and development in cultured mammalian embryos.

Authors:  Alan Bolnick; Mohammed Abdulhasan; Brian Kilburn; Yufen Xie; Mindie Howard; Paul Andresen; Alexandra M Shamir; Jing Dai; Elizabeth E Puscheck; Daniel A Rappolee
Journal:  J Assist Reprod Genet       Date:  2016-05-26       Impact factor: 3.412

Review 6.  Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.

Authors:  Leopoldo O Tso; Michael F Costello; Luiz Eduardo T Albuquerque; Régis B Andriolo; Cristiane R Macedo
Journal:  Cochrane Database Syst Rev       Date:  2014-11-18

Review 7.  Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation.

Authors:  Maureen M B Schulte; Jui-he Tsai; Kelle H Moley
Journal:  Reprod Sci       Date:  2014-12-07       Impact factor: 3.060

Review 8.  Metformin: new understandings, new uses.

Authors:  Ripudaman S Hundal; Silvio E Inzucchi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: a case report.

Authors:  M Guido; D Romualdi; C Belosi; L Selvaggi; A Lanzone
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

Review 10.  Metformin in polycystic ovary syndrome: systematic review and meta-analysis.

Authors:  Jonathan M Lord; Ingrid H K Flight; Robert J Norman
Journal:  BMJ       Date:  2003-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.